Andrew H. Galligan, Chief Financial Officer at NEVRO CORP (NVRO), sold 20,000 shares at $52.01 ($1.0M) on 2015-11-17, disclosed to the SEC on 2015-11-19.
Scheduled sale ($1.0M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.24 | 18,500 | $948K | 92.4% |
| 2 | $52.01 | 1,500 | $78K | 7.6% |
| Total | $51.30 avg | 20,000 | $1.0M | 100% |
| Filing → |
| NVRO | SELL | 2020-01-10 | $4.3M | — | Filing → |
| NVRO | SELL | 2020-01-08 | $334K | — | Filing → |
| NVRO | SELL | 2019-11-26 | $1.3M | — | Filing → |